Barcelona, Spain: Professor Robert Mansel, Chair of the 11th European Breast Cancer Conference (EBCC-11) and Emeritus Professor of Surgery at Cardiff University School of Medicine, UK, has called for men to be included in trials to improve treatments for breast cancer.
They may not, because the hormones involved in the cancer are different, but until this is investigated in trials, we do not know what is the best treatment for them.
They could benefit from more conservative surgery that preserves the nipple and areola." Breast cancer in men is 100 times less common than in women, with a lifetime risk of developing it of about one in 1,000 men.
In the UK there are approximately 390 men diagnosed with breast cancer each year, compared to 54,800 cases in women.
The European Organisation for Research and Treatment of Cancer (EORTC), the Breast International Group (BIG) and the North American Breast Cancer Groups are coordinating an effort to analyse clinical data from a prospective international registry of male breast cancer patients.